A Scientific Breakthrough Inspired by Nikola Tesla
In 1894, Nikola Tesla reported producing what he called “shadowgraphs” — internal images created before Wilhelm Röntgen formally announced the discovery of X-rays in 1895. Tesla’s early experiments suggested that high-voltage electrical systems could generate penetrating radiation with imaging capability.
Today, in collaboration with international research partners in the United States, the United Kingdom, and Canada, nuclear physicist Dr. Jan Rak and his team have experimentally reconstructed one of Tesla’s lesser-known concepts — and the results are remarkable
The project, known as ShadowGraph, appears to generate a form of radiation capable of producing internal images similar to X-rays — yet without the harmful biological effects typically associated with ionizing radiation
What Has Been Achieved So Far
According to the 2026 technical roadmap
, the team has:
- Achieved reproducible imaging under controlled laboratory conditions
- Designed and constructed an advanced Tesla transformer with a controlled spark-gap system
- Established in-house proprietary lamp manufacturing capability, ensuring rapid iteration and intellectual property control
- Conducted early biological response studies comparing ShadowGraph exposure to conventional X-rays
Experimental shadowgraph images have already been produced, including imaging of biological specimens and human extremities (January–February 2026 experiments)
Preliminary Biological Findings
One of the most intriguing findings comes from comparative biological studies conducted by Griffin G. Brock Laboratories (USA)
dd67e388-457a-4086-9449-5c13385…
In controlled experiments using radish seeds exposed to 0–100 Roentgen:
- Conventional X-ray exposure showed a typical negative dose-response trend.
- ShadowGraph exposure showed no clear monotonic negative biological response.
While these are early-stage results and further validation is required, the preliminary data suggests that ShadowGraph emission may operate through a mechanism not fully described by conventional X-ray physics.
This is now entering a formal emission classification phase in 2026.
Potential Applications
If validated through spectral characterization and regulatory assessment, ShadowGraph technology may have transformative implications across multiple industries
Primary Application
- Medical Imaging
- Potential DNA-safe imaging
- Improved collimation and tomography capability
Additional Applications
- Geophysics & mining exploration
- Airport security scanning
- Non-destructive industrial testing (defectoscopy)
- Nuclear waste remediation research
One particularly bold research direction suggests the radiation may influence the lifetime of exposed radioactive material — a hypothesis that requires rigorous validation but opens significant scientific discussion.
2026 Validation Roadmap
The project is currently entering a critical validation phase
- Q2 2026: Spectral validation – determine emission class
- Q3 2026: Stability testing – confirm reproducibility
- Q4 2026: IP strategy – secure defensible intellectual property position
- Q4 2026: Spin-off creation – commercialization vehicle
The primary technical risk at present is regulatory classification pending full spectral characterization.
However, the strategic advantage lies in proprietary in-house lamp manufacturing, allowing controlled scaling and IP protection.
Capital Requirement
The current capital requirement for full validation and development is approximately:
CZK 3,949,539 (~USD 192,000 equivalent)
This funding supports:
- Spectral characterization equipment
- Imaging validation systems
- Prototype tube production
- Laboratory operations for six months
- IP protection strategy
Key milestone objectives:
- Emission classification complete
- Basic radiology validation
- IP secured
Invitation to Strategic Investors
The ShadowGraph project stands at a potential inflection point.
If spectral validation confirms a distinct emission class with reduced biological harm, this platform may represent a defensible deep-tech imaging breakthrough with cross-industry scalability.
We are currently seeking:
- Strategic research partners
- Technology investors
- Medical imaging innovators
- Industrial and energy sector collaborators
Investors interested in participating in this early-stage validation and commercialization phase are invited to contact us directly.
This is a rare opportunity to support a project that bridges Tesla’s visionary physics with modern experimental reconstruction and applied science.
For expressions of interest, partnership inquiries, or technical briefings, please contact us through:
More in attached document
